Cardiovascular screening prior to stem cell transplantation in the United Kingdom

Autor: David G. Gent, Muhammad Saif, Julia Lee, Arpad G. Tóth, Eleni Tholouli, Rebecca Dobson, David J. Wright

Publikováno v: eJHaem, Vol 3, Iss 4, Pp 1455-1458 (2022)

Externí odkaz: https://doaj.org/article/066a9db699444801b31db9fbd3d56c1d

The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus

Autor: David G Gent, Rebecca Dobson

Publikováno v: European Cardiology Review, Vol 18, Iss , Pp - (2023)

The expansion of the therapeutic armamentarium available to oncologists and haematologists has led to a significant improvement in cancer survival; however, many of the available treatments carry a risk of toxicity to the heart. Cardio-oncology has e

Externí odkaz: https://doaj.org/article/80d932cebe184c458153cbc2c2864cbd

Trabectedin Cardiotoxicity in Soft Tissue Sarcoma:A Case Series and Clinical Insights

Autor: David G. Gent, Nasim Ali, Anna Olsson-Brown, Gregory Y.H. Lip, David J. Wright, Rebecca Dobson

Publikováno v: Gent, D G, Ali, N, Olsson-Brown, A, Lip, G Y H, Wright, D J & Dobson, R 2022, ' Trabectedin Cardiotoxicity in Soft Tissue Sarcoma : A Case Series and Clinical Insights ', Case Reports in Oncology, vol. 15, no. 3, pp. 950-959 . https://doi.org/10.1159/000526256

Trabectedin is a chemotherapeutic used to treat advanced soft tissue sarcoma and relapsed platinum-sensitive ovarian cancer. Although it is associated with a low incidence of cardiotoxicity, when this occurs it can be fatal or significantly compromis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d96667e3cc496a0995b210616a63de00
https://vbn.aau.dk/da/publications/813d6e5f-a613-4a90-96db-1d898118231a